INTRODUCTION
Patient addresses were geocoded and distances to all monitors calculated (Haversine formula). Daily pollutant exposures were estimated by the inverse-distance-squared weighted average of daily levels from monitors within 50km (17) . Long-term exposures were estimated using average pollutant levels for the 1-, 3-, and 5-year periods prior to ICU admission and short-term exposures using levels for the prior 3 days and 6 weeks.
Findings for 1-, 3-and 5-year ozone exposures were similar; 3-year data are presented.
Because no significant associations between long-term exposures to SO 2 , PM 2.5 and PM 10 and risk of ARDS were observed, these are presented in the Supplement. As there were no associations between any short-term air pollutant exposure and ARDS, these data are not shown. For reference, correlations between pollutant levels are shown in Supplementary Table E1 .
Statistical Analysis. Demographic and clinical data were compared between ARDS and non-ARDS patients using Pearson's chi-squared tests and Wilcoxon rank-sum tests Missing values of regression covariates were multiply imputed with predictive mean matching (18) to avoid case-wise deletion of patient records. We fit logistic regression models to examine the relationship between ARDS and pollutant levels controlling for pre-specified confounders including age, race, sex, enrollment month (to control for season), current smoking, alcohol use, insurance status (as a proxy for socioeconomic status), median household income, metro vs. non-metro residence, distance to VUMC, APACHE-II, injury severity score (ISS, trauma subset only) and blunt vs. penetrating trauma. A restricted cubic spline with 3 knots was used for age, month, and APACHE-II to permit nonlinear associations. Data analyses were performed using R Version 3 (R Core Team). highly significant (p = 0.007). Ozone was significantly associated with ARDS only in current smokers and not in non-smokers ( Figure 4B ). There was no association between alcohol and ARDS in this study and no interaction between alcohol and ozone (p-value for interaction: 0.60) or any other pollutant.
Sensitivity analyses. To determine if accuracy of exposure estimates affected the findings, we restricted analysis to patients living within 15 km of a monitor. None of the analyses were substantively changed (not shown). In a second sensitivity analysis, we included the 80 patients with "indeterminate" ARDS status as controls. Ozone exposure was still associated with ARDS (OR 1.56, 95% CI 1.25, 1.94) especially in trauma patients (OR 2.27, 95% CI 1.46, 3.51). The interaction of ozone exposure with smoking was unchanged (p < 0.001).
DISCUSSION
In critically ill patients at risk for ARDS, long-term exposure estimates for ozone based on residential address were associated with development of ARDS. Importantly, this association was independent of other known risk factors for ARDS such as age and severity of illness. In addition, this association persisted after adjustment for potential confounders including metro versus non-metro dwelling, source of insurance and median household income as indicators of socioeconomic status, and distance of residence from the study hospital, which was included to control for possible unmeasured differences in severity of illness that could lead to transfer to VUMC of sicker patients from remote hospitals with different levels of pollutant exposure. We also found an association of long-term exposure to NO 2 and risk of ARDS; however, in two pollutant models with ozone and NO 2 , only ozone remained significant. There was no association between exposure estimates for other pollutants (SO 2 , PM 2.5 and PM 10 ) and ARDS. To our knowledge, this is the first report of an association between ambient air pollution and risk of ARDS. Furthermore, the observed association occurred at relatively low levels of exposure that fall within current EPA standards, suggesting that these observations, if reproduced, could be relevant even in areas with low levels of ambient ozone. Based on these findings, long-term exposure to ozone could represent a previously unrecognized risk factor for development of ARDS.
Although ozone exposure has not previously been associated with ARDS, both acute and chronic ozone exposure have been associated with respiratory disease in experimental and clinical studies. Acute ozone exposure induces acute lung injury in animals, primarily by producing an oxidant-mediated injury to the lung epithelium that leads to increased permeability and lung inflammation (20). Controlled short-term exposure to ozone (at doses that are much higher than ambient pollutant levels) in humans also causes airway inflammation and oxidant injury (21-23). In epidemiologic studies, acute exposure to high ozone levels has been associated with asthma exacerbations (24). Both ozone and NO 2 exposure over the preceding 6 weeks were associated with acute exacerbation of idiopathic pulmonary fibrosis (25), a syndrome that shares pathologic features with ARDS. Chronic ozone exposure has been associated with decreased lung growth in children (26, 27) and decreased small airways function in young adults (28). In a study of over 400,000 subjects, chronic ozone exposure was associated with mortality from respiratory causes (29); data on ARDS as a cause of respiratory mortality were not available in that study.
In the current study, the association between ARDS and ozone exposure was strongest in patients at risk for ARDS from severe trauma. Since it is well established that traumaassociated ARDS is clinically and pathophysiologically different from ARDS from other causes (30), ambient ozone exposure may uniquely prime the lung to develop ARDS in the setting of severe trauma. The higher rate of smoking in the trauma group (54%) compared to the non-trauma group (34%, P < 0.0001) may have potentiated the effects of ambient ozone exposure. Since the incidence of ARDS in the trauma group was lower (32%) than in the non-trauma patients (40%), another potential explanation is that other ARDS risk factors such as sepsis represent such a potent and overwhelming stimulus for acute lung injury that the contribution of chronic ozone exposure to risk of ARDS is less apparent. Finally, it is possible that patients who develop ARDS as a result of trauma spend more time outdoors than patients with other ARDS risk factors leading to higher exposure levels to ambient pollutants.
Smoking has only recently been recognized to be an independent risk factor for ARDS.
Prospective studies report a strong association between cigarette smoking and risk of ARDS in severe trauma (4), non-pulmonary sepsis (6), lung transplant recipients (31) and patients receiving blood transfusions (5) . Indeed, given the low levels of ambient ozone exposure in the VALID cohort, it is somewhat surprising that the effect of smoking on development of ARDS does not overwhelm the signal from ozone exposure. Potential mechanisms for potentiation of ARDS by smoking have considerable overlap with mechanisms of ozone-induced lung injury (32) . These include harmful effects on lung epithelial and endothelial permeability and function (33, 34) , pro-inflammatory effects due to changes in neutrophil alveolar macrophage trafficking and function, and effects on cell-mediated and humoral immunity (35, 36) . Smoking and air pollutant exposure have previously been shown to have synergistic effects on risk of obesity, pulmonary function deficits and lung cancer (37-39). The strong interaction between smoking and ozone exposure in the current study suggests that ozone exposure may also potentiate the harmful effects of tobacco smoke on the lung with regard to ARDS risk. This observation is important since both smoking and air pollution exposure are potentially modifiable environmental risk factors for developing ARDS.
Although we found an association between long-term NO 2 exposure and ARDS, this association was not significant after controlling for ozone levels. There are several potential explanations. First, since nitrogen oxides are the most prevalent ambient reactant for ozone formation, the association between NO 2 and risk of ARDS may only be indicative of ozone exposure. Second, since nitrogen oxides are predominantly trafficrelated pollutants, exposure estimates based on regional monitors may not be accurate.
Studies that analyze distance to roadway might be better suited to determine the relationship between NO 2 or other traffic-related pollutants such as PM 2.5 and PM 10 and development of ARDS. Finally, since there were fewer monitoring stations for NO 2 than for ozone, this analysis had less power.
This study has several strengths. First, we studied a large heterogeneous cohort of critically ill medical, surgical, and trauma patients, enhancing the potential generalizability of the findings. Second, the patients were rigorously phenotyped prospectively for both ARDS risk factors and development of ARDS by physician investigators. This is in sharp contrast to many epidemiologic studies that have relied on inherently less reliable death certificate data or administrative coding for patient phenotyping. Third, residential addresses and dates of admissions were used for exposure estimates, allowing for individualized rather than population or neighborhood-based exposure estimates. Finally, the extensive prospective data collection in the VALID study allowed us to control for a large number of potential confounders, decreasing but not eliminating the possibility of residual confounding.
This study has some limitations. First, patients were drawn from only one geographic region, and air pollutant effects may differ by geographic region. Second, as in any study that does not directly measure air pollutant levels, there is the possibility of exposure misclassification. To mitigate the concern of exposure misclassification, a sensitivity analysis included only patients who lived within 15 km of a monitor with similar results.
Exposure misclassification could also be caused by reliance on the address provided at hospital admission; information about prior addresses during the exposure period was not available. Exposure misclassification may also arise from exposures that occur away from the residence including at the place of occupation. Number of hours spent outdoors versus indoors could also affect total exposure and would not be captured in our estimates.
Third, the possibility of residual confounding and in particular residual spatial confounding remains. We attempted to mitigate this concern by including socioeconomic status (measured by insurance source and zip code-based median household income), metro versus non-metro residence and distance to the study hospital in the regression models. However, given the concern for potential unmeasured confounders, it will be important to confirm these findings in geographically diverse patient groups with both higher and lower levels of ozone exposure. Fourth, in this exploratory study, we did not aim to strictly control the type I error rate. In order to minimize the likelihood of identifying false positive associations, we pre-specified the variables and interaction terms to include in the primary models prior to data examination. Subgroup analyses such as trauma/non-trauma were also pre-specified. Although we did not adjust for multiple comparisons, our primary finding of ozone-ARDS association has a p-value of <0.001, which would be significant with post-hoc significance adjustment using a conservative Bonferroni method. Finally, because this was an observational study, causality cannot be inferred.
In summary, in a large group of rigorously phenotyped critically ill patients, we report an association between long-term ozone exposure levels and risk of developing ARDS. This risk was potentiated by cigarette smoking and was strongest in patients with severe trauma as their ARDS risk factor. These findings indicate that ozone exposure may be a previously unrecognized environmental risk factor for ARDS. In an unadjusted analysis of (A) all patients and of (B) the subset with trauma as their ARDS risk factor, patients in the 2 nd , 3 rd and 4 th quartiles of 3-year ozone exposure estimates were significantly more likely to develop ARDS (P < 0.001). For 3A, the incidence of ARDS was 28.0%, (95% CI 23. Table E1   2   6   Table E2  7   Table E3  8   Table E4  9   Table E5  10   Table E6 11 Table E7 12 Table E8  13   Table S9  14   Table E10  15   Table E11  16   Table E12  17   Table E13   Table E14   Table E15   Table E16   18 Quality Standard for ozone If a monitor used more than one instrument then the average of the daily summaries for each was used. Since ozone levels are usually only monitored in warmer months in the study region, data were restricted to April through September; data from all months were used for other pollutants.
Patient addresses were geocoded (Google Maps Application Programming Interface) and the distances to all monitors calculated using the Haversine formula. Each patient's daily exposure to a pollutant was estimated by the inverse-distance-squared weighted average of daily levels from all monitors within 50km of the patient's address, based on the assumption that local levels of ambient pollutants reasonably estimate an individual's exposure (E10). We investigated both long-term exposures using the averages of 1-, 3-, and 5-year periods prior to ICU admission and short-term exposures using the average pollutant levels for the 3 days and 6 weeks prior to ICU admission. 4 Lower quartile is 13.9, and upper quartile is 98.0. 5 Lower quartile is 37.9k, and upper quartile is 56.5k.
